Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.6K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.6K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

964
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
964
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

1.7K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.7K
Depressants01:28

Depressants

487
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
487
Drug Therapy01:28

Drug Therapy

315
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
315
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

842
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
842

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bipolar spectrum disorders in divers: risks, recognition, and recommendations.

Diving and hyperbaric medicine·2026
Same author

Assessing dive fitness in individuals with autism spectrum disorder.

Diving and hyperbaric medicine·2025
Same author

Psychosis and diving.

Diving and hyperbaric medicine·2025
Same author

Diving with psychotropic medication: review of the literature and clinical considerations.

Diving and hyperbaric medicine·2023
Same author

Children and diving, a guideline.

Diving and hyperbaric medicine·2020
Same author

Diving and attention deficit hyperactivity disorder.

Diving and hyperbaric medicine·2019
Same journal

Returning to diving and hyperbaric exposure after pulmonary vein isolation for atrial fibrillation.

Diving and hyperbaric medicine·2026
Same journal

Cerebral arterial oxygen embolism as a complication of hyperbaric oxygen treatment: a case report.

Diving and hyperbaric medicine·2026
Same journal

Spontaneous resolution of choroidal neovascular membrane in the fellow eye during hyperbaric oxygen treatment for retinal artery occlusion: a case report.

Diving and hyperbaric medicine·2026
Same journal

The role of hyperbaric oxygen treatment in a case of pyomyositis.

Diving and hyperbaric medicine·2026
Same journal

Recreational and technical rebreather fatalities and diving safety status.

Diving and hyperbaric medicine·2026
Same journal

Evidence‑informed decision aid for fitness‑to‑dive assessment after otologic surgery.

Diving and hyperbaric medicine·2026
See all related articles

Related Experiment Video

Updated: Feb 16, 2026

Training Rats to Voluntarily Dive Underwater: Investigations of the Mammalian Diving Response
11:56

Training Rats to Voluntarily Dive Underwater: Investigations of the Mammalian Diving Response

Published on: November 12, 2014

12.9K

Diving and antidepressants.

Abraham L Querido1

  • 1Larenseweg 14, Hilversum, The Netherlands, bram@praktijkquerido.nl.

Diving and Hyperbaric Medicine
|December 15, 2017
PubMed
Summary
This summary is machine-generated.

Diving with antidepressants is not well understood and carries risks like drowsiness and bleeding. This article offers expert-based guidelines for recreational divers using antidepressants.

Keywords:
Diving medicineFitness to diveMedicationsRecreational divingReview articleSide effects

More Related Videos

A Complex Diving-For-Food Task to Investigate Social Organization and Interactions in Rats
10:29

A Complex Diving-For-Food Task to Investigate Social Organization and Interactions in Rats

Published on: May 8, 2021

4.7K
The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

40.0K

Related Experiment Videos

Last Updated: Feb 16, 2026

Training Rats to Voluntarily Dive Underwater: Investigations of the Mammalian Diving Response
11:56

Training Rats to Voluntarily Dive Underwater: Investigations of the Mammalian Diving Response

Published on: November 12, 2014

12.9K
A Complex Diving-For-Food Task to Investigate Social Organization and Interactions in Rats
10:29

A Complex Diving-For-Food Task to Investigate Social Organization and Interactions in Rats

Published on: May 8, 2021

4.7K
The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

40.0K

Area of Science:

  • Diving Medicine
  • Pharmacology

Background:

  • Psychoactive medications, including antidepressants, present potential risks for recreational divers.
  • Limited research exists on the safety of diving while using antidepressant medications.
  • Potential interactions include somnolence, convulsions, bleeding tendencies, altered glucose metabolism, and psychiatric effects.

Framework:

  • Expert opinion-based guidelines for recreational diving with antidepressants.
  • Guidelines developed from a 2015 meeting of the Dutch Association for Diving Medicine.

Implementation:

  • Consideration of somnolence, bleeding risk, and potential worsening of decompression illness (DCI).
  • Exploration of fluoxetine's potential anti-inflammatory effects relevant to DCI.
  • Assessment of psychiatric side effects in the diving context.

Implications:

  • Provides a framework for managing risks associated with antidepressant use in divers.
  • Highlights the need for further research into the specific interactions between antidepressants and diving.
  • Aims to enhance diver safety by informing practice and policy.